Early short-term treatment with exogenous hydrogen sulfide postpones the transition from prehypertension to hypertension in spontaneously hypertensive rat

References

• Yuan S, Patel RP, Kevil CG. Working with nitric oxide and hydrogen sulfide in biological systems. Am J Physiol Lung Cell Mol Physiol 2015;308:L403–L415.
   PubMed Web of Science ®Google Scholar
• Hsu CN, Huang LT, Lau YT, et al. The combined ratios of L-arginine, asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats. Transl Res 2012;159:90–98.
   PubMed Web of Science ®Google Scholar
• Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999;43:542–548.
   PubMed Web of Science ®Google Scholar
• Tain YL, Joles JA. Reprogramming: A preventive strategy in hypertension focusing on the kidney. Int J Mol Sci 2015;17:E23.
   PubMed Web of Science ®Google Scholar
• Paul BD, Snyder SH. H₂S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 2012;13:499–507.
   PubMed Web of Science ®Google Scholar
• Kolluru GK, Shen X, Kevil CG. A tale of two gases: NO and H2S, foes or friends for life? Redox Biol 2013;1:313–318.
   PubMed Web of Science ®Google Scholar
• Bir SC, Kolluru GK, McCarthy P, et al. Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis. J Am Heart Assoc 2012;1:e004093.
   PubMed Web of Science ®Google Scholar
• Harrap SB, Van der Merwe WM, Griffin SA, et al. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990;16:603–614.
   PubMed Web of Science ®Google Scholar
• Tain YL, Hsu CN, Lin CY, et al. Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats. Eur J Pharmacol 2011;670:561–565.
   PubMed Web of Science ®Google Scholar
• Lu M, Liu YH, Goh HS, et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 2010;21:993–1002.
   PubMed Web of Science ®Google Scholar
• Snijder PM, Frenay AR, Koning AM, et al. Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage. Nitric Oxide 2014;42:87–98.
   PubMed Web of Science ®Google Scholar
• Al-Magableh MR, Kemp-Harper BK, Hart JL. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertens Res 2015;38:13–20.
   PubMed Web of Science ®Google Scholar
• Pan LL, Liu XH, Gong QH, et al. Role of cystathionineγ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal 2012;17:106–118.
   PubMed Web of Science ®Google Scholar
• Shibuya N, Kimura H. Production of hydrogen sulfide from d-cysteine and its therapeutic potential. Front Endocrinol (Lausanne) 2013;4:87.
   PubMedGoogle Scholar
• Zhu YZ, Wang ZJ, Ho P, et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 2007;102:261–268.
   PubMed Web of Science ®Google Scholar
• Tain YL, Hsu CN, Lee CT, et al. N-Acetylcysteine prevents programmed hypertension in male rat offspring born to suramin-treated mothers. Biol Reprod. 2016;9:8.
   Web of Science ®Google Scholar
• Tai IH, Sheen JM, Lin YJ, et al. Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet. Nitric Oxide 2016;53:6–12.
   PubMed Web of Science ®Google Scholar
• Ahmad FU, Sattar MA, Rathore HA, et al. Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail 2012;34:203–210.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang LK, Zhang CY, et al. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats. Hypertens Res 2008;31:1619–1630.
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008;322:587–590.
   PubMed Web of Science ®Google Scholar
• Predmore BL, Lefer DJ, Gojon G. Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal 2012;17:119–140.
   PubMed Web of Science ®Google Scholar
• Kredich NM, Foote LJ, Keenan BS. The stoichiometry and kinetics of the inducible cysteine desulfhydrase from Salmonella typhimurium. J Biol Chem 1973;248:6187–96.
   Google Scholar
• Koning AM, Frenay AR, Leuvenink HG, van Goor H. Hydrogen sulfide in renal physiology, disease and transplantation –the smell of renal protection. Nitric Oxide 2015;46:37–49.
   PubMed Web of Science ®Google Scholar
• Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 2011;41:113–121.
   PubMed Web of Science ®Google Scholar
• Sherman RC, Langley-Evans SC. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin Sci (Lond) 1998;94:373–381.
   PubMed Web of Science ®Google Scholar
• Laggner H, Hermann M, Esterbauer H, et al. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens 2007;25:2100–2104.
   PubMed Web of Science ®Google Scholar
• Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004;313:22–27.
   PubMed Web of Science ®Google Scholar
• Geng B, Cui Y, Zhao J, et al. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R1608–R1618.
   PubMed Web of Science ®Google Scholar
• Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007;232:138–146.
   PubMed Web of Science ®Google Scholar
• Lu M, Liu YH, Goh HS, et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 2010;21:993–1002.
   PubMed Web of Science ®Google Scholar
• Aslami H, Pulskens WP, Kuipers MT, et al. Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic status. PLoS One 2013;8:e63497.
   PubMed Web of Science ®Google Scholar
• Ahangarpour A, Abdollahzade Fard A, Gharibnaseri MK, Jalali T, Rashidi I. Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat. Vet Res Forum 2014;5:121–127.
   PubMedGoogle Scholar